Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana
- S. Weiser, W. Wolfe, +8 authors R. Marlink
- Medicine
- Journal of acquired immune deficiency syndromes
- 1 November 2003
Background: Botswana has the highest rate of HIV infection in the world, estimated at 36% among the population aged 15‐49 years. To improve antiretroviral (ARV) treatment delivery, we conducted a… Expand
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques.
- M. Daniel, N. Letvin, +6 authors R. Desrosiers
- Biology, Medicine
- Science
- 7 June 1985
The isolation of a T-cell tropic retrovirus from three immunodeficient macaques and one macaque with lymphoma is described. The morphology, growth characteristics, and antigenic properties of this… Expand
Antiretroviral regimens in pregnancy and breast-feeding in Botswana.
- R. Shapiro, M. Hughes, +27 authors M. Essex
- Medicine
- The New England journal of medicine
- 16 June 2010
BACKGROUND
The most effective highly active antiretroviral therapy (HAART) to prevent mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) in pregnancy and its efficacy during… Expand
Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
- S. Lockman, R. Shapiro, +14 authors M. Essex
- Medicine
- The New England journal of medicine
- 1 June 2007
BACKGROUND
A single dose of nevirapine during labor reduces perinatal transmission of human immunodeficiency virus type 1 (HIV-1) but often leads to viral nevirapine resistance mutations in mothers… Expand
Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.
- Jennifer Y. Chen, H. Ribaudo, +11 authors R. Shapiro
- Medicine
- The Journal of infectious diseases
- 1 December 2012
BACKGROUND
It is unknown whether adverse birth outcomes are associated with maternal highly active antiretroviral therapy (HAART) in pregnancy, particularly in resource-limited settings.
METHODS
We… Expand
A randomized trial of multivitamin supplements and HIV disease progression and mortality.
- W. Fawzi, G. Msamanga, +8 authors D. Hunter
- Medicine
- The New England journal of medicine
- 1 July 2004
BACKGROUND
Results from observational studies suggest that micronutrient status is a determinant of the progression of human immunodeficiency virus (HIV) disease.
METHODS
We enrolled 1078 pregnant… Expand
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
- M. Cohen, Y. Chen, +33 authors T. Fleming
- Medicine
- The New England journal of medicine
- 18 July 2016
BACKGROUND
An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused… Expand
Male circumcision: an acceptable strategy for HIV prevention in Botswana
- P. Kebaabetswe, S. Lockman, +4 authors R. Shapiro
- Medicine
- Sexually transmitted infections
- 1 June 2003
Background: Male circumcision is known to reduce the risk of acquiring HIV, but few studies have been performed to assess its acceptability among either children or adults in sub-Saharan Africa.… Expand
SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICA
Serological evidence is presented here suggesting that a virus closely related to simian T-lymphotropic virus type III (STLV-III) infects man in Senegal, west Africa, a region where AIDS or… Expand
Prevention of HIV-1 infection with early antiretroviral therapy.
- M. Cohen, Y. Chen, +32 authors T. Fleming
- Medicine
- The New England journal of medicine
- 10 August 2011
BACKGROUND
Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples.
METHODS
In nine countries, we… Expand
...
1
2
3
4
5
...